| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 7 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 18 |
| NetGPI | no | yes: 0, no: 18 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005777 | peroxisome | 6 | 1 |
| GO:0005778 | peroxisomal membrane | 6 | 1 |
| GO:0016020 | membrane | 2 | 1 |
| GO:0020015 | glycosome | 7 | 1 |
| GO:0031090 | organelle membrane | 3 | 1 |
| GO:0031903 | microbody membrane | 5 | 1 |
| GO:0042579 | microbody | 5 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0098588 | bounding membrane of organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B047
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006996 | organelle organization | 4 | 14 |
| GO:0009987 | cellular process | 1 | 14 |
| GO:0016043 | cellular component organization | 3 | 14 |
| GO:0016559 | peroxisome fission | 6 | 14 |
| GO:0048285 | organelle fission | 5 | 14 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 14 |
| GO:0032535 | regulation of cellular component size | 4 | 1 |
| GO:0044375 | regulation of peroxisome size | 5 | 1 |
| GO:0065007 | biological regulation | 1 | 1 |
| GO:0065008 | regulation of biological quality | 2 | 1 |
| GO:0090066 | regulation of anatomical structure size | 3 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.325 |
| CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.450 |
| CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.315 |
| CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.482 |
| CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.287 |
| CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.323 |
| CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.455 |
| CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.273 |
| DOC_MAPK_gen_1 | 164 | 174 | PF00069 | 0.274 |
| DOC_MAPK_gen_1 | 42 | 49 | PF00069 | 0.573 |
| DOC_MAPK_gen_1 | 71 | 81 | PF00069 | 0.548 |
| DOC_MAPK_MEF2A_6 | 176 | 185 | PF00069 | 0.272 |
| DOC_PP1_RVXF_1 | 89 | 96 | PF00149 | 0.510 |
| DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.462 |
| DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.498 |
| DOC_USP7_UBL2_3 | 164 | 168 | PF12436 | 0.316 |
| LIG_Actin_WH2_2 | 136 | 152 | PF00022 | 0.295 |
| LIG_Actin_WH2_2 | 178 | 194 | PF00022 | 0.236 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.605 |
| LIG_LIR_Gen_1 | 2 | 11 | PF02991 | 0.436 |
| LIG_LIR_Nem_3 | 132 | 138 | PF02991 | 0.372 |
| LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.431 |
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.560 |
| LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.494 |
| LIG_NRBOX | 6 | 12 | PF00104 | 0.538 |
| LIG_Pex14_2 | 135 | 139 | PF04695 | 0.293 |
| LIG_Pex14_2 | 23 | 27 | PF04695 | 0.477 |
| LIG_Pex14_2 | 92 | 96 | PF04695 | 0.549 |
| LIG_PTB_Apo_2 | 98 | 105 | PF02174 | 0.476 |
| LIG_PTB_Phospho_1 | 98 | 104 | PF10480 | 0.455 |
| LIG_REV1ctd_RIR_1 | 25 | 33 | PF16727 | 0.554 |
| LIG_REV1ctd_RIR_1 | 93 | 101 | PF16727 | 0.521 |
| LIG_SH2_CRK | 116 | 120 | PF00017 | 0.390 |
| LIG_SH2_CRK | 21 | 25 | PF00017 | 0.464 |
| LIG_SH2_GRB2like | 215 | 218 | PF00017 | 0.462 |
| LIG_SH2_PTP2 | 46 | 49 | PF00017 | 0.447 |
| LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.437 |
| LIG_SH2_STAT5 | 190 | 193 | PF00017 | 0.256 |
| LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.484 |
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.447 |
| LIG_SH3_3 | 191 | 197 | PF00018 | 0.192 |
| LIG_UBA3_1 | 59 | 64 | PF00899 | 0.488 |
| MOD_CK1_1 | 198 | 204 | PF00069 | 0.233 |
| MOD_CK1_1 | 38 | 44 | PF00069 | 0.486 |
| MOD_CK1_1 | 52 | 58 | PF00069 | 0.465 |
| MOD_CK2_1 | 160 | 166 | PF00069 | 0.246 |
| MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.171 |
| MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.314 |
| MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.309 |
| MOD_GSK3_1 | 172 | 179 | PF00069 | 0.368 |
| MOD_GSK3_1 | 45 | 52 | PF00069 | 0.443 |
| MOD_N-GLC_1 | 172 | 177 | PF02516 | 0.382 |
| MOD_N-GLC_1 | 216 | 221 | PF02516 | 0.359 |
| MOD_NEK2_1 | 216 | 221 | PF00069 | 0.644 |
| MOD_PIKK_1 | 195 | 201 | PF00454 | 0.171 |
| MOD_PIKK_1 | 35 | 41 | PF00454 | 0.523 |
| MOD_Plk_4 | 190 | 196 | PF00069 | 0.264 |
| MOD_Plk_4 | 211 | 217 | PF00069 | 0.321 |
| MOD_Plk_4 | 99 | 105 | PF00069 | 0.527 |
| MOD_SUMO_rev_2 | 120 | 126 | PF00179 | 0.391 |
| MOD_SUMO_rev_2 | 163 | 170 | PF00179 | 0.246 |
| TRG_DiLeu_BaEn_2 | 87 | 93 | PF01217 | 0.542 |
| TRG_ENDOCYTIC_2 | 116 | 119 | PF00928 | 0.390 |
| TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.455 |
| TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.442 |
| TRG_ER_diArg_1 | 90 | 92 | PF00400 | 0.371 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJG1 | Leptomonas seymouri | 32% | 100% |
| A0A0N1PCA1 | Leptomonas seymouri | 81% | 100% |
| A0A0S4IU25 | Bodo saltans | 51% | 100% |
| A0A1X0NR15 | Trypanosomatidae | 53% | 100% |
| A0A3S5H7J8 | Leishmania donovani | 32% | 100% |
| A0A3S7X1W3 | Leishmania donovani | 92% | 100% |
| A0A422N9F6 | Trypanosoma rangeli | 53% | 100% |
| A4HD72 | Leishmania braziliensis | 25% | 100% |
| A4HGS9 | Leishmania braziliensis | 30% | 100% |
| A4HGT0 | Leishmania braziliensis | 85% | 100% |
| A4I3V6 | Leishmania infantum | 33% | 100% |
| A4I3V7 | Leishmania infantum | 91% | 100% |
| D0A924 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
| E9B046 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
| Q4Q838 | Leishmania major | 87% | 100% |
| Q4Q839 | Leishmania major | 32% | 100% |
| V5BEE7 | Trypanosoma cruzi | 58% | 100% |